Kezar Life Sciences, Inc. (KZR) Preferred Stock Liabilities (2017)

Kezar Life Sciences has reported Preferred Stock Liabilities for 1 years, with the latest figure at $77.9 million in Q4 2017.

• Quarterly Preferred Stock Liabilities changed N/A year-over-year to $77.9 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $77.9 million (changed N/A YoY) and the FY2017 annual result came in at $77.9 million, up 176.59% from the prior year.
• Preferred Stock Liabilities held at $77.9 million in Q4 2017 per KZR's latest filing.
• Over five years, Preferred Stock Liabilities peaked at $77.9 million in Q4 2017 and troughed at $77.9 million in Q4 2017.